title: [Efficacy, tolerance and incidence of risk factors of Alpress in the treatment of arterial hypertension].
abstract: The system release of prazosin confirms the good efficacy and tolerance of Alpress in the hypertension treatment. Prazosin has favorable effects on some risk factors, and it therefore seem interesting to conduct a study in a pannel of hypertensive patients, to emphasize the quality of Alpress response, based on these criteria. This experiment demonstrated the efficacy and tolerance levels of Alpress as well as its favorable effect on cholesterol.
authors.affiliation: Clinique Claude Bernard, Metz.
authors.forename: J L
authors.initials: JL
authors.lastname: Neimann
mesh_terms: D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000627:therapeutic use*; D012307:Risk Factors; D013607:Tablets
chemical_list: D003692:Delayed-Action Preparations; D013607:Tablets; D011224:Prazosin
vernacular_title: Efficacité, tolérance et incidence sur les facteurs de risques de l'Alpress dans le traitement de l'hypertension artérielle.